These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23454301)

  • 1. Global metabolomic analysis of heart tissue in a hamster model for dilated cardiomyopathy.
    Maekawa K; Hirayama A; Iwata Y; Tajima Y; Nishimaki-Mogami T; Sugawara S; Ueno N; Abe H; Ishikawa M; Murayama M; Matsuzawa Y; Nakanishi H; Ikeda K; Arita M; Taguchi R; Minamino N; Wakabayashi S; Soga T; Saito Y
    J Mol Cell Cardiol; 2013 Jun; 59():76-85. PubMed ID: 23454301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defect of delta-sarcoglycan gene is responsible for development of dilated cardiomyopathy of a novel hamster strain, J2N-k: calcineurin/PP2B activity in the heart of J2N-k hamster.
    Mitsuhashi S; Saito N; Watano K; Igarashi K; Tagami S; Shima H; Kikuchi K
    J Biochem; 2003 Aug; 134(2):269-76. PubMed ID: 12966077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the human myocardial proteome in inflammatory dilated cardiomyopathy by label-free quantitative shotgun proteomics of heart biopsies.
    Hammer E; Goritzka M; Ameling S; Darm K; Steil L; Klingel K; Trimpert C; Herda LR; Dörr M; Kroemer HK; Kandolf R; Staudt A; Felix SB; Völker U
    J Proteome Res; 2011 May; 10(5):2161-71. PubMed ID: 21417265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective activity and isoform of the Na,K-ATPase in the dilated cardiomyopathic hamster.
    Paganelli F; Mougenot R; Maixentt JM
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):255-60. PubMed ID: 11354998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster.
    Serose A; Prudhon B; Salmon A; Doyennette MA; Fiszman MY; Fromes Y
    Basic Res Cardiol; 2005 Mar; 100(2):161-70. PubMed ID: 15611844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy.
    Alexander D; Lombardi R; Rodriguez G; Mitchell MM; Marian AJ
    Eur J Clin Invest; 2011 May; 41(5):527-38. PubMed ID: 21155767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-induced dilated cardiomyopathy is characterized by increased levels of fibrotic extracellular matrix proteins and reduced amounts of energy-producing enzymes.
    Nishtala K; Phong TQ; Steil L; Sauter M; Salazar MG; Kandolf R; Kroemer HK; Felix SB; Völker U; Klingel K; Hammer E
    Proteomics; 2011 Nov; 11(22):4310-20. PubMed ID: 21954127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy.
    Iwata Y; Ohtake H; Suzuki O; Matsuda J; Komamura K; Wakabayashi S
    Cardiovasc Res; 2013 Sep; 99(4):760-8. PubMed ID: 23786999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters.
    Kondoh H; Sawa Y; Miyagawa S; Sakakida-Kitagawa S; Memon IA; Kawaguchi N; Matsuura N; Shimizu T; Okano T; Matsuda H
    Cardiovasc Res; 2006 Feb; 69(2):466-75. PubMed ID: 16423569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry.
    Hirayama A; Kami K; Sugimoto M; Sugawara M; Toki N; Onozuka H; Kinoshita T; Saito N; Ochiai A; Tomita M; Esumi H; Soga T
    Cancer Res; 2009 Jun; 69(11):4918-25. PubMed ID: 19458066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamsters.
    Hirata Y; Soeki T; Akaike M; Sakai Y; Igarashi T; Sata M
    Biomed Pharmacother; 2009 Dec; 63(10):781-6. PubMed ID: 19906506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamsters.
    Crespo MJ; Cangiano JL; Altieri PI; Escobales N
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):547-52. PubMed ID: 22370958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic and Metabolomics Insights into Dilated Cardiomyopathy.
    Ampong I
    Ann Nutr Metab; 2022; 78(3):147-155. PubMed ID: 35472668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of P2X1alpha-sarcoglycan (adhalin) expression levels in failing human dilated cardiomyopathic left ventricles.
    Berry DA; Balcar VJ; Barden JA; Keogh A; dos Remedios CG
    Electrophoresis; 2000 Nov; 21(17):3857-62. PubMed ID: 11271504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonists of stretch-activated ion channels restore contractile function in hamster dilated cardiomyopathy.
    Nicolosi AC; Kwok CS; Bosnjak ZJ
    J Heart Lung Transplant; 2004 Aug; 23(8):1003-7. PubMed ID: 15312831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of canine mitochondrial protein expression in natural and induced forms of idiopathic dilated cardiomyopathy.
    Lopes R; Solter PF; Sisson DD; Oyama MA; Prosek R
    Am J Vet Res; 2006 Jun; 67(6):963-70. PubMed ID: 16740088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of TRPV2-targeting functional antibody ameliorating dilated cardiomyopathy and muscular dystrophy in animal models.
    Iwata Y; Wakabayashi S; Ito S; Kitakaze M
    Lab Invest; 2020 Feb; 100(2):324-337. PubMed ID: 31896817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-platform comparison of methods for quantitative metabolomics of primary metabolism.
    Büscher JM; Czernik D; Ewald JC; Sauer U; Zamboni N
    Anal Chem; 2009 Mar; 81(6):2135-43. PubMed ID: 19236023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.